Buy or sell SutroVax stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
SutroVax Stock
SutroVax is a biopharmaceutical company
About SutroVax Stock
SutroVax is a recently established biopharmaceutical company developing vaccines for infectious disease targets with an initial emphasis on best-in-class conjugate vaccines and protein-based vaccines. SutroVax is an independent company that was spun out of Sutro Biopharma with an exclusive license to Sutro Biopharma’s Xpress CF™ platforms for cell free protein synthesis and site-specific conjugation.
Funding History
| July 2015 | $22.0M |
|---|---|
| March 2017 | $4.0M |
| March 2017 | $60.0M |
| June 2018 | $85.0M |
Management
Chairman
Moncef Slaoui
Founder & CEO
Grant E. Pickering
Press
OutSourcing-Pharma.com - Jun, 12 2018
FierceBiotech - May, 25 2018
The Pharma Letter - Mar, 7 2018
PR Newswire (press release) - Oct, 11 2017
PR Newswire (press release) - Jul, 19 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
